日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

CPX-351 vs daunorubicin, cytarabine, and gemtuzumab ozogamicin in older adults with non-adverse-risk AML: the NCRI AML18 trial

CPX-351 与柔红霉素、阿糖胞苷和吉妥珠单抗治疗老年非不良风险 AML 患者的疗效比较：NCRI AML18 试验

期刊:Blood
影响因子:23.1
doi:10.1182/blood.2025031006
Knapper, Steven; Dillon, Laura W; Babu, Malavika; Thomas, Abin; Thomas, Ian; Hourigan, Christopher S; Andrew, Georgia; Dillon, Richard; Gilkes, Amanda; Marquez Almuina, Nuria; King, Sophie; McCarthy, Nicholas; Bahr, Reem; Al-Ali, Rasha W; Stone, Louisa; Coats, Tom; Byrne, Jennifer; Green, Simone; Overgaard, Ulrik Malthe; Sellar, Rob S; Dennis, Mike; Mehta, Priyanka; Hills, Robert; Freeman, Sylvie D; Russell, Nigel H
351
发表日期：2026
文献求助 收藏

CLinNET: An Interpretable and Uncertainty-Aware Deep Learning Framework for Multi-Modal Clinical Genomics

CLinNET：一种用于多模态临床基因组学的可解释且考虑不确定性的深度学习框架

期刊:Advanced Science
影响因子:14.1
doi:10.1002/advs.202512842
Bakhshayeshi, Ivan; Hosseini, Mohammad Mahdi; Argha, Ahmadreza; Zahedi, Roxana; Lovell, Nigel H; Alinejad-Rokny, Hamid
发表日期：2026
文献求助 收藏

The promise of GLP-1 receptor agonists for neurodegenerative diseases

GLP-1受体激动剂在神经退行性疾病治疗中的应用前景

期刊:Journal of Clinical Investigation
影响因子:13.6
doi:10.1172/JCI194745
Athauda, Dilan; Greig, Nigel H; Meissner, Wassilios G; Foltynie, Thomas; Gandhi, Sonia
信号转导
神经科学
GLP-1
发表日期：2026
文献求助 收藏

All patients with acute myeloid leukemia and FLT3-ITD should be transplanted in first remission. Also in the era of tyrosine kinase inhibitors? - the CON

所有患有急性髓系白血病且伴有FLT3-ITD突变的患者都应在首次缓解期接受移植。即使在酪氨酸激酶抑制剂时代也是如此吗？——反对

期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2025.288786
Russell, Nigel H; Lewis, Katie D
白血病
信号转导
FLT3
发表日期：2026
文献求助 收藏

Programmable spatiotemporal control of CRISPR-Cas12a: Engineering precision for next-generation gene editing and diagnostics

CRISPR-Cas12a的可编程时空控制：为下一代基因编辑和诊断提供精准的工程技术

期刊:Synthetic and Systems Biotechnology
影响因子:4.4
doi:10.1016/j.synbio.2026.01.035
Seelan, Anmol; Shah, Labdhi; Shamshad, Samer; Khanda, Milan; Vira, Darsh; Singh, Harpreet; Chopra, Hitesh; Greig, Nigel H
发表日期：2026
文献求助 收藏

LRP6 β-Propeller Destabilization: Novel Variant, Phenotype and Diagnostic Implications in Tooth Agenesis

LRP6 β螺旋桨不稳定：牙齿缺失中的新变异、表型和诊断意义

期刊:International Dental Journal
影响因子:3.7
doi:10.1016/j.identj.2025.109367
Intarak, Narin; Ghasemnejad, Tohid; Fakhruddin, Kausar Sadia; Kamal, Ayaana; Prommanee, Sasiprapa; Jahanian, Khadijeh Hoda; Lovell, Nigel H; Alinejad-Rokny, Hamid; Porntaveetus, Thantrira
发表日期：2026
文献求助 收藏

Anti-inflammatory and pro-proliferative effects of fasudil in human trisomy 21 neural progenitor cells

法舒地尔对人类21三体神经祖细胞的抗炎和促增殖作用

期刊:
影响因子:
doi:10.64898/2026.03.19.712922
Baxter, Laura L; Lee, Sarah E; Fuentes, Kevin A; Mosley, Iman A; Raymond, Jonathan D; Guedj, Faycal; Zhou, Di; Slonim, Donna K; Glotfelty, Elliot J; Tweedie, David; Grieg, Nigel H; Bianchi, Diana W
细胞生物学
发表日期：2026
文献求助 收藏

Comprehensive evaluation of ACMG/AMP-based variant classification tools

对基于 ACMG/AMP 的变异分类工具进行全面评估

期刊:
影响因子:
doi:10.1093/bioinformatics/btaf623
Ghasemnejad, Tohid; Liang, Yuheng; Jahanian, Khadijeh Hoda; Eidi, Milad; Salmaninejad, Arash; Abedini, Seyedeh Sedigheh; Horta, Fabrizzio; Lovell, Nigel H; Porntaveetus, Thantrira; Grosser, Mark; Aarabi, Mahmoud; Alinejad-Rokny, Hamid
发表日期：2026
文献求助 收藏

Treatment Intensification With Either Fludarabine, AraC, G-CSF and Idarubicin, or Cladribine Plus Daunorubicin and AraC on the Basis of Residual Disease Status in Older Patients With AML: Results From the NCRI AML18 Trial

根据老年 AML 患者的残余疾病状态，采用氟达拉滨、阿糖胞苷、粒细胞集落刺激因子和伊达比星，或克拉屈滨联合柔红霉素和阿糖胞苷强化治疗：来自 NCRI AML18 试验的结果

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.24.00259
Russell, Nigel H; Thomas, Abin; Hills, Robert K; Thomas, Ian; Gilkes, Amanda; Almuina, Nuria Marquez; Burns, Sarah; Marsh, Lucy; Vyas, Paresh; Metzner, Marlen; McCarthy, Nicholas; Andrew, Georgia; Byrne, Jennifer; Sellar, Rob S; Kelly, Richard; Cahalin, Paul; Overgaard, Ulrik Malthe; Mehta, Priyanka; Dennis, Mike; Knapper, Steven; Freeman, Sylvie D
细胞生物学
粒细胞
发表日期：2025
文献求助 收藏

A pooled analysis of 3 large multicenter trials confirms a survival advantage for NPM1 (mut) AML in MRD(neg) remission after intensive induction

一项对3项大型多中心试验的汇总分析证实，在强化诱导治疗后达到微小残留病灶阴性缓解的NPM1突变型急性髓系白血病患者具有生存优势。

期刊:Hemasphere
影响因子:14.6
doi:10.1002/hem3.70198
Döhner, Konstanze; Döhner, Hartmut; Späth, Daniela; Kapp-Schwoerer, Silke; Gilkes, Amanda; Thomas, Ian; Johnson, Sean; Potter, Nicola; Bevan, Yana; Othman, Jad; Russell, Nigel H; Röllig, Christoph; Thiede, Christian; Bornhäuser, Martin; Oellerich, Thomas; Hood, Tressa; Elder, Jenna; Carvajal, Luis A; DiMartino, Jorge; Dillon, Richard
白血病
NPM
发表日期：2025
文献求助 收藏